Back to companies
Avalo Therapeutics, Inc.
AVTXUSNASDAQPharmaceuticals & HealthcareAvalo Therapeutics, Inc.
Revenue
$59,000
YoY -86.6%
Operating income
-$72.9mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API